Encore
Experience the talks from the NEI Psychopharmacology Congress and pre-conference Workshop again, or for the first time!
Select year: Available to guests!     lock
pre-conference workshop
Forward Focus: Transitioning From Adolescence to Adulthood With ADHD
Timothy E Wilens, MD

In this presentation, Dr. Timothy Wilens explores some of the neurobiological differences as well as the social and cognitive challenges that may present during the transition from adolescence to adulthood in patients with ADHD.

CME credit: 1.00

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Forward Focus: Transitioning from Childhood to Adolescence with ADHD
Adelaide S Robb, MD

The transition from childhood to adolescence can bring many challenges for patients with ADHD. Here, Dr. Adelaide Robb discusses some of the academic and social challenges that come with childhood and adolescence for patients with ADHD as well as best practices for treating the whole patient based on the specific needs of the individual.

CME credit: 1.00

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Goodnight Brain: The Science of Healthy Sleep
Stephen M Stahl, MD, PhD

Sleep is a little understood but critical activity in which every human takes part. Here, Dr. Stephen Stahl discusses our current knowledge of the neurobiology of sleep as well as the consequences of altered sleep-wake patterns including cancer risk, dementia, and psychiatric conditions.

CME credit: 0.75

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Panic at Play: Optimizing Outcomes in Pediatric Anxiety
Jeffrey Strawn, MD

Treating anxiety in pediatric patients can be challenging. Here, Dr. Jeffrey Strawn provides guidance for choosing anxiety medications based on efficacy, safety, and tolerability data.

CME credit: 0.75

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Living Better Longer: The Formula for Successful Brain Aging
Gary W Small, MD

We are now living longer than ever and one of our greatest challenges is to find ways to remain physically, mentally, and emotionally healthy as we approach older ager. In this presentation, Dr. Gary Small discusses cognitive decline as individuals age as well as pharmacologic and non-pharmacologic interventions that may assist in maintaining brain health as we age.

CME credit: 0.75

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Inflamed in the Membrane: The Gut-Brain Interaction
Roger S McIntyre, MD, FRCPC

Increasingly, evidence points to an intricate relationship between the gut microbiome and the brain. In this presentation, Dr. Roger McIntyre investigates the nature of the gut-brain relationship and discusses the intricate links between gut microbiome, inflammation, and mental health.

CME credit: 1.00

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



Make No "Mixtake": Depression With Mixed Features in Children and Adolescents
Stephen M Stahl, MD, PhD

Mental illness in pediatric patients is unique and requires treatment strategies that may differ from those in adults. In this presentation, Dr. Stephen Stahl describes the importance of detecting mixed features in depression and how mixed features should inform diagnosis and treatment to improve health outcomes of children and adolescents.

CME credit: 0.75

Get started
Download slides (PDF)
Download audio: Click to listen or right click to download



NEI Psychopharmacology Congress
I Blocked D2 and All I Got Was This Lousy Side Effect: What to Do When D2 Isn’t Enough
Andrew J Cutler, MD

Given the high rates of treatment resistance and relapse in schizophrenia, and the implications in terms of patient outcomes, novel strategies and therapeutic approaches beyond D2 receptor blockade are being intensively studied. In this presentation, Dr. Andrew Cutler provides the most current information on pharmacological treatment options beyond targeting the D2 receptor, along with novel pharmaceutical approaches that involve other neurotransmitter systems, instead of dopamine.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Preventing Relapse Today: Making a Difference for a Lifetime
Leslie Citrome, MD, MPH

In this presentation, Dr. Leslie Citrome discusses strategies to optimize adherence to treatment, including addressing side effects and offering different formulation options. Additionally, a comparison of available long-acting injectable formulations, including newly available agents and how to implement them in clinical practice will be addressed.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Differential Diagnosis and Treatment of Antipsychotic-related Movement Disorders
Laxman B Bahroo, DO

Use of dopamine receptor blocking agents (DRBAs) may result in a variety of extrapyramidal symptoms (EPS), such as akathisia, tardive dyskinesia, and drug-induced parkinsonism. In this presentation, Dr. Laxman Bahroo provides practical tools for the assessment and early detection of movement disorders and how to differentiate between the various types of movement disorders, along with the most current individualized treatment approaches to effectively manage symptoms.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



So Many Options, So Little Focus: Navigating the World of ADHD Medications
David W Goodman, MD, FAPA

In this presentation, Dr. David Goodman explores the various options for pharmacological and nonpharmacological treatments to help address the needs of individual patients.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Update on the Assessment and Treatment of Eating Disorders
Leslie Citrome, MD, MPH

In this presentation, Dr. Leslie Citrome discusses the diagnostic criteria for the different eating disorder as well as their effective treatment modalities including certain specific psychotherapy and pharmacologic approaches.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



More Than Meets the Eye: Diagnosing and Treating Bipolar Depression
Stephen M Stahl, MD, PhD

It is often a challenge to successfully and efficiently diagnose bipolar depression as its presentation can be very difficult to distinguish from unipolar depression. However, the differential diagnosis is key as bipolar and unipolar depression have very different treatment strategies. Here, Dr. Stephen Stahl reviews the factors that may help with recognizing when a major depressive is part of a bipolar presentation as well as optimal strategies for treating patients with bipolar depression.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Adding Insult to Injury: The Challenge of Pseudobulbar Affect
Andrew J Cutler, MD

Pseudobulbar affect (PBA) is a disorder of affect characterized by bouts of laughing and or crying that are incongruous with a person's mood. In this presentation, Dr. Andrew Cutler will provide the latest hypotheses regarding the underlying causes and neurobiology of PBA. Strategies to address the underlying dysfunctional neurocircuitry of PBA using pharmacological agents will also be discussed.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Legislation and Legalization of Marijuana Use: How to Protect the Patient
Kari L Franson, PharmD, PhD

You have questions, Dr. Franson has answers. Learn what evidence (if any) exists for the common conditions for which cannabis is used, the potential risks of long-term use, and some key considerations to convey to patients.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



PsychopharMYTHology: Beliefs Widely Held by Psychopharmacologists That Are Actually Not True
Rajnish Mago, MD

There are some myths surrounding psychopharmacology we know to be clearly untrue, such as ‘the same prescriptions work for everyone’ or ‘your patients will feel better immediately’. However, in this presentation Dr. Rajnish Mago discusses more challenging misconceptions psychopharmacologists may encounter.

CME credits: 1.25

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Is It Safe? Using Psychotropics in Patients With Hepatic Issues
Jonathan M Meyer, MD

Dr. Jonathan Meyer discusses the most important issues in patients with hepatic dysfunction, and provides a practical method for assessing dosage adjustment for medications in patients with hepatic dysfunction.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Cases of Comorbid Substance Use
Roger S McIntyre, MD, FRCPC

Substance use—past or current—can complicate the treatment decisions for patients with mental illness. Here, Dr. McIntyre presents cases that illustrate the dilemmas and offers guidance for these complicated situations

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Psychiatric Emergency: Assessment and Management of Agitation
Rona J Hu, MD

Agitation is a serious and potentially dangerous consequence of many psychiatric conditions. In this presentation, Dr. Rona Hu explores the neurobiology of aggressive behaviors and discusses pharmacological and non-pharmacological strategies for ameliorating agitation and preventing the escalation to violence in patients with mental illness.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



What's Shakin': Brain Stimulation Therapies for Psychiatric Disorders
William M Sauvé, MD

For patients with treatment-resistant depression, stimulation therapies such as transcranial magnetic stimulation (TMS) have significantly decreased depressive symptoms. Recently, there has been an explosion of novel research on the utilization of TMS to treat a variety of mental disorders beyond depression, such as obsessive compulsive disorder. In this presentation, Dr. William Sauvé provides an exciting update on current applications of brain stimulation techniques for the treatment of neuropsychiatric conditions.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



If You Treat Schizophrenia You Must Prescribe Clozapine: Here's Why and How
Jonathan M Meyer, MD

In this presentation, Dr. Jonathan Meyer offers a practical perspective for utilizing clozapine in treatment resistant schizophrenia as well as reviews clozapine’s unique side effect profile, including how to manage drug interactions and common early adverse effects.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Impact, Diagnosis, and Treatment of Personality Disorders
Thomas L Schwartz, MD

Personality disorders are often best thought of in dimensional terms versus discrete entities and often are highly comorbid with other psychiatric disorders making categorical diagnosis and resultant studies very difficult. In this presentation, Dr. Thomas Schwartz will discuss the impact, diagnosis, comorbidities, and treatment of personality disorders.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Psychosis and Dementia in Parkinson's Disease and Other Alpha-Synucleinopathies
Jonathan M Meyer, MD

Neurodegenerative disorders, such as Parkinson's disease present increasingly prevalent health issues in society today, and patients may present with dementia, psychosis, and agitation. The accumulation of α-synuclein protein into Lewy body inclusions is a hallmark feature of Parkinson's disease and other neurodegenerative disorders. In this presentation, Dr. Jonathan Meyer addresses the important role that alpha-synucleinopathies have in neurodegenerative disorders and the most effective treatment strategies available.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



Treatment-Resistant Depression: Current Best Practices and a Look to the Future
Roger S McIntyre, MD, FRCPC

One-third of depressed patients do not achieve an adequate clinical response to available treatment and are considered to have treatment-resistant depression. In this presentation, Dr. Roger McIntyre discusses new research and therapeutic options for identifying and treating resistant depression.

CME credit: 1.00

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download



A Primer on CAMs for Peripartum Depression
Stephen M Stahl, MD, PhD

Women who experience depression during the peripartum period are often uncomfortable utilizing conventional pharmacotherapies due to issues such as concern for the developing fetus. As such, many women turn to use of complementary and alternative medicines (CAMs) in order to reduce their symptoms of depression. In this presentation, Dr. Stephen Stahl explores the safety and efficacy of a variety of CAMs including both herbal and physical remedies.

CME credit: 0.75

Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download